Business Development

We partner with and invest in companies who share our mission of improving the health, well-being and performance of animals and the people who care for them.

Strengthening our Commitment to the Animal Health Industry

We must be willing to work together across both internal and external stakeholders to truly shape the future of animal health. Our Business Development team explores partnerships with significant potential to leverage transformative technologies and develop products and solutions that will directly address unmet customer needs and further advance the animal health industry.

What We’re Looking For

We are actively seeking early, medium- and late-stage investment opportunities.

We focus on entering new or adjacent high-growth categories and markets, novel & cutting-edge science and technology platforms, and complementary technology and solutions that augment our existing portfolio and R&D resources and programs for companion animals and livestock, including pharmaceuticals and biologics, delivery systems and vaccines.

Key Recent Transactions

Acquisition of a global leader in animal health digital tracking, traceability and monitoring technology

Acquisition of first fully owned Chinese vaccines manufacturing facility

Acquisition of a privately held business focused on the development and manufacture of vaccines for livestock, headquartered in Uruguay

Acquisition of a leading privately held producer of animal health products in Brazil

Acquisition of a privately held business focused on the development and manufacture of vaccines for food production and companion animals

Acquisition of a fish health and fish welfare company

Acquisition of a previous Merck Animal Health Ventures investment; accelerates the SenseHub Feedlot offering

Acquisition of a virtual fencing company providing technology solutions to cattle producers and ranchers

Acquisition of a previous Merck Animal Health Ventures investment; provides poultry operators with precision health monitoring solutions that identify and accelerate treatment of illnesses

Acquisition of DNA-traceability technology for livestock, supporting farm-to-table identification

Acquisition of the U.S. rights to the SENTINEL brand of parasiticides for companion animals

Asset acquisition of herd management solutions and milk-testing sensors for the dairy segment

Animal Health Ventures

Investing in Innovation and Advanced Technology Companies

Our Animal Health Ventures team, as an extension of Business Development, partners and invests in promising early-stage companies to bring state-of-the-art animal health technologies to market.

As innovators, our goal is to partner, test and co-build new businesses (and business models) that address unmet customer needs, but play in adjacent but consequential markets that could transform our core existing markets.

The Value of Our Partnership

Our team includes technology and finance experts, animal scientists, veterinarians and prior founders who focus on identifying and investing in companies with early-stage technologies, devices, software and solutions.

We work side-by-side with our partners, bringing value through our:

Scientific approach and biopharma expertise

End-to-end understanding of our customers’ businesses and operations

Animal ID and Monitoring expertise

Customer access and global scale

Broader investor network within the animal and pet tech industry